Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial

Harris V., Holmes J., Gbinigie-Thompson O., Rahman NM., Richards DB., Hayward G., Dorward J., Lowe DM., Standing JF., Breuer J., Khoo S., Petrou S., Hood K., Ahmed H., Carson-Stevens A., Nguyen-Van-Tam JS., Patel MG., Saville BR., Francis N., Thomas NPB., Evans P., Dobson M., Png ME., Lown M., van Hecke O., Jani BD., Hart ND., Butler D., Cureton L., Patil M., Andersson M., Coates M., Bateman C., Davies JC., Raymundo-Wood I., Ustianowski A., Yu L-M., Hobbs FDR., Little P., Butler CC., Moftah A., Goodman A., Halifax R., Turnbull C., Sundaralingam A., Agyeman A., Shah D., Brown J., Thalasselis C., Woodall MNJ., Yongblah F., Howell A., Patel K., Hussain I., Penfold R., Hutchinson S., Poonian S., Imlach M., Popoola O., Irving G., Pora A., Jacobsen N., Prasad V., Kennard J., Prasad R., Khan U., Razzaq O., Knox K., Richardson S., Krasucki C., Royal S., Law T., Safa A., Lee R., Sehdev S., Lester N., Sevenoaks T., Lewis D., Sheikh A., Lunn J., Short V., Mackintosh C., Singh Sidhu B., Mathukia M., Singh I., Moore P., Soni Y., Morton S., Wilson P., Murphy D., Wingfield D., Nally R., Wong M., Ndukauba C., Wooding N., Ogundapo O., Woods S., Okeke H., Yong J., Ahmed T., Allcock D., Atherton G., Beltran-Martinez A., Benedict OE., Bird N., Brennan L., Burns G., Butler M., Butler D., Carson-Stevens A., Cheng Z., Danson R., De Kare-Silver N., Dhasmana D., Dickson J., Engamba S., Fisher S., Fox R., Frost E., Gaunt R., Ghosh S., Gilkar I., Goodman A., Granier S., Packham A., Dowsell S., Gulati R., Patel A.

DOI

10.1016/s1473-3099(24)00431-6

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

09/2024

Permalink Original publication